Kindred Biosciences (KIN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts KIN Hot Sheet
Join SI Premium – FREE
Kindred Biosciences (NASDAQ: KIN) reported Q2 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). R
For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
